heiBIB: Christopoulos, Petros

Christopoulos, Petros Prof. Dr. med.Universität HeidelbergHeidelberg

Refine publication list

Year of publication

Type of Publication

List

Language

English (119)
German (1)

Co-author (Univ. of Heidelberg)

more ...

Co-author (external)

more ...

Publications in heiBIB

Pan, Leyun: Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients / Leyun Pan, Christos Sachpekidis, Jessica Hassel, Petros Christopoulos, Antonia Dimitrakopoulou-Strau… , 2025. - 15 S. : Illustrationen
In: European journal of nuclear medicine and molecular imaging, ISSN 1619-7089. 52(2025), 2, Seite 623-637
DOI: 10.1007/s00259-024-06879-4
Wiesweg, Marcel: Oligometastatic non-small cell lung cancer : impact of local and contemporary systemic treatment approaches on clinical outcome / Marcel Wiesweg, Claudia Küter, Johannes Schnorbach, Julius Keyl, Martin Metzenmacher, Jelena Cvetkov… , [25 September 2024]. - 12 S.
In: International journal of cancer, ISSN 1097-0215. 156(2025), 4, Seite 776-787
DOI: 10.1002/ijc.35199
Saalfeld, Felix: Small cell transformation in EGFR-mutated non-small cell lung cancer : DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy / Felix Carl Saalfeld, Johanna Möller, Petros Christopoulos, Carina Wenzel, Anna Rasokat, Xuejun Alice… , December 2024. - 8 S.
In: European journal of cancer, ISSN 1879-0852. 213(2024) vom: Dez., Artikel-ID 115065, Seite 1-8
DOI: 10.1016/j.ejca.2024.115065
Bischoff, Philip: Outcome of first-line treatment with pembrolizumab according to KRAS/TP53 mutational status for nonsquamous programmed death-ligand 1-High (≥50%) NSCLC in the German national network genomic medicine lung cancer / Philip Bischoff, MD, Martin Reck, MD, Tobias Overbeck, MD, Petros Christopoulos, MD, Julia Röper, Ph… , May 2024. - 15 S. : Illustrationen
In: Journal of thoracic oncology, ISSN 1556-1380. 19(2024), 5, Artikel-ID 5, Seite 803-817
DOI: 10.1016/j.jtho.2023.12.015
Richtmann, Sarah: The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer / Sarah Richtmann, Sebastian Marwitz, Thomas Muley, Hannu Koistinen, Petros Christopoulos, Michael Tho… , October 2024. - 13 S. : Illustrationen
In: Translational research, ISSN 1878-1810. 272(2024) vom: Okt., Seite 177-189
DOI: 10.1016/j.trsl.2024.02.007
Hahnemann, Laura: Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases : clinical outcome and prognostic factors / L. Hahnemann, A. Krämer, C. Fink, C. Jungk, M. Thomas, P. Christopoulos, J. W. Lischalk, J. Meis, J.… , 21 April 2024. - 10 S.
In: Clinical and translational radiation oncology, ISSN 2405-6308. 46(2024), Artikel-ID 100782, Seite 100782-1-100782-10
DOI: 10.1016/j.ctro.2024.100782
Bochtler, Tilmann: Management of a pregnant ALK-positive lung cancer patient with alectinib-induced pneumonitis and bilateral globus pallidus necrosis postpartum / Tilmann Bochtler, Petros Christopoulos, Kai Schlamp, Frank Winkler, Alwin Krämer, January 2024. - 5 S. : Illustrationen
In: Clinical lung cancer, ISSN 1938-0690. 25(2024), 1 vom: Jan., Seite 72-76
DOI: 10.1016/j.cllc.2023.08.016
Hu, Wenbin: A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement / Wenbin Hu, Jiaming Zhao, Guoxia Wang, Qihao Wang, Mingming Deng, Jie Shen, Paul Hofman, Edyta Maria … , May 31, 2024. - 13 S. : Illustrationen
In: Translational Lung Cancer Research, ISSN 2226-4477. 13(2024), 5 vom: Mai, Seite 1150-1162
DOI: 10.21037/tlcr-24-352
Christopoulos, Petros: Unravelling the puzzle of immunotherapeutic efficacy in lung cancer / Petros Christopoulos, May 31, 2024. - 4 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 13(2024), 5 vom: Mai, Seite 1173-1176
DOI: 10.21037/tlcr-24-221
Budczies, Jan: KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma / Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Raj… , 12 June 2024. - 10 S. : Illustrationen
In: British journal of cancer, ISSN 1532-1827. 131(2024), 3, Seite 524-533
DOI: 10.1038/s41416-024-02746-z
Tao, Linglong: RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker / Linglong Tao, Xiaoyu Xu, Zhengxuying Fang, Petros Christopoulos, Diego Cortinovis, Yi Lu, March 31, 2024. - 21 S. : Illustrationen
In: Translational cancer research, ISSN 2219-6803. 13(2024), 3 vom: März, Seite 1533-1553
DOI: 10.21037/tcr-23-2016
Illini, Oliver: Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON) : an international real-world safety and efficacy analysis / Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir … , April 2024. - 19 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 25(2024), 7, special issue vom: Apr., Artikel-ID 3992, Seite 1-19
DOI: 10.3390/ijms25073992
Budczies, Jan: Tumour mutational burden : clinical utility, challenges and emerging improvements / Jan Budczies, Daniel Kazdal, Michael Menzel, Susanne Beck, Klaus Kluck, Christian Altbürger, Constan… , October 2024. - 18 S. : Illustrationen
In: Nature reviews, ISSN 1759-4782. 21(2024), 10 vom: Okt., Seite 725-742
DOI: 10.1038/s41571-024-00932-9
Ding, Yizong: Preliminary experience of surgery after neoadjuvant immunotherapy combined with chemotherapy for stage-IIIB non-small cell lung cancer / Yizong Ding, Xiaojing Zhao, Petros Christopoulos, Travis C. Geraci, Yujie Fu, July 30, 2024. - 10 S. : Illustrationen
In: Journal of thoracic disease, ISSN 2077-6624. 16(2024), 7 vom: Juli, Seite 4645-4654
DOI: 10.21037/jtd-24-908
Stratmann, Jan A.: Sotorasib in KRAS G12C-mutated non-small cell lung cancer : a multicenter real-world experience from the compassionate use program in Germany / Jan A. Stratmann, Friederike C. Althoff, Paula Doebel, Jacqueline Rauh, Arne Trummer, Ali Nuri Hüner… , April 2024
In: European journal of cancer, ISSN 1879-0852. 201(2024), Seite 113911
DOI: 10.1016/j.ejca.2024.113911
Jehn, Julia: miR-Blood - a small RNA atlas of human blood components / Julia Jehn, Franziska Trudzinski, Rastislav Horos, Judith Schenz, Florian Uhle, Markus A. Weigand, M… , 02 February 2024. - 13 S. : Illustrationen
In: Scientific data, ISSN 2052-4463. 11(2024), Artikel-ID 164, Seite 1-13
DOI: 10.1038/s41597-024-02976-z
Gente, Karolina: Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease / Karolina Gente, Manuel Feisst, Dorothea Marx, Karel D. Klika, Petros Christopoulos, Jürgen Graf, Jul… , 1 April 2024. - 10 S. : Illustrationen
In: Annals of the rheumatic diseases, ISSN 1468-2060. 83(2024), 8, Seite 974-983
DOI: 10.1136/ard-2023-224839
Menzel, Michael: Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors / Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin… , March 2024. - 10 S. : Illustrationen
In: The journal of pathology: clinical research, ISSN 2056-4538. 10(2024), 2 vom: März, Artikel-ID e354, Seite 1-10
DOI: 10.1002/cjp2.354
Longuespée, Rémi: Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome : a case report / Rémi Longuespée, Julia Kunz, Margaux Fresnais, Kathrin I. Foerster, Jürgen Burhenne, Michael Thomas,… , January 2024. - 6 S.
In: British journal of clinical pharmacology, ISSN 1365-2125. 90(2024), 1, Seite 344-349
DOI: 10.1111/bcp.15924
Bozorgmehr, Farastuk: Correction : Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 10 August 2023. - 1 S.
In: BMC cancer, ISSN 1471-2407. 23(2023), 1 vom: Aug., Artikel-ID 740, Seite 1
DOI: 10.1186/s12885-023-11270-x
Fink, Christoph Andreas: Comorbidity in limited disease small-cell lung cancer : age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy / Christoph A. Fink, Fabian Weykamp, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Kri… , 24 July 2023. - 7 S. : Illustrationen
In: Clinical and translational radiation oncology, ISSN 2405-6308. 42(2023) vom: Sept., Artikel-ID 100665, Seite 1-7
DOI: 10.1016/j.ctro.2023.100665
Eichhorn, Florian: Prognostic impact of the immune-cell infiltrate in N1-positive non-small-cell lung cancer / Florian Eichhorn, Andreas Weigert, Rajender Nandigama, Laura V. Klotz, Jochen Wilhelm, Mark Kriegsma… , 28 June 2023. - 12 S.
In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 8, Seite 706-716.e1
DOI: 10.1016/j.cllc.2023.06.013
Sikosek, Tobias: Early detection of lung cancer using small RNAs / Tobias Sikosek, PhD, Rastislav Horos, PhD, DVM, Franziska Trudzinski, MD, Julia Jehn, PhD, Maurice F… , November 2023. - 20 S. : Illustrationen
In: Journal of thoracic oncology, ISSN 1556-1380. 18(2023), 11 vom: Nov., Seite 1504-1523
DOI: 10.1016/j.jtho.2023.07.005
Zerdes, Ioannis: Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases / I. Zerdes, C. Kamali, A. Koulouris, M. Elsayed, J. Schnorbach, P. Christopoulos, & G. Tsakonas, 20 November 2023. - 7 S.
In: ESMO open, ISSN 2059-7029. 8(2023), 6, Artikel-ID 102069, Seite 1-7
DOI: 10.1016/j.esmoop.2023.102069
Ou, Sai-Hong: Response to “NGS, the New Global Standard?” : Letters to the editor / Sai-Hong Ignatius Ou, MD, PhD, Jin-Liern Hong, PhD, Petros Christopoulos, MD, PhD, Huamao M. Lin, Ph… , October 2023. - 2 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 18(2023), 10, Seite e116-e118
DOI: 10.1016/j.jtho.2023.07.022
Li, Hui: An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy : a case report / Hui Li, Jingjing Liu, Shaowei Lan, Rui Zhong, Yanan Cui, Petros Christopoulos, Erin L. Schenk, Takaa… , Nov 24, 2023. - 12 S. : Illustrationen
In: Translational Lung Cancer Research, ISSN 2226-4477. 12(2023), 12, Seite 2538-2549
DOI: 10.21037/tlcr-23-656
Blasi, Miriam: Pembrolizumab alone or with chemotherapy for 70+ year-old lung cancer patients : a retrospective study / Miriam Blasi, Jonas Kuon, Rajiv Shah, Farastuk Bozorgmehr, Florian Eichhorn, Stephan Liersch, Albrec… , November 2023. - 9 S.
In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 7 vom: Nov., Seite e282-e290
DOI: 10.1016/j.cllc.2023.06.010
Li, Bowen: Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion : a case report / Bowen Li, Ziqi Jia, Zhicheng Huang, Jianchao Xue, Yadong Wang, Chao Guo, Xiaoyan Si, Zexin Chen, Ji … , November 30, 2023. - 8 S. : Illustrationen
In: Translational Lung Cancer Research, ISSN 2226-4477. 12(2023), 11, Seite 2322-2329
DOI: 10.21037/tlcr-23-487
Şeker-Cin, Huriye: Analysis of rare fusions in NSCLC : genomic architecture and clinical implications / Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hau… , October 2023. - 14 S.
In: Lung cancer, ISSN 1872-8332. 184(2023) vom: Okt., Artikel-ID 107317, Seite 1-14
DOI: 10.1016/j.lungcan.2023.107317
Gente, Karolina: Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events / Karolina Gente, Leonore Diekmann, Lea Daniello, Julia Will, Manuel Feisst, Victor Olsavszky, Janine … , September 19, 2023. - 15 S. : Illustrationen
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. 11(2023), 9, Artikel-ID e007557, Seite 1-15
DOI: 10.1136/jitc-2023-007557
Romanovsky, Eva: Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis / Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel … , 14 April 2023. - 14 S.
In: Cell death discovery, ISSN 2058-7716. 9(2023) vom: Apr., Artikel-ID 126, Seite 1-14
DOI: 10.1038/s41420-023-01413-1
Negrao, Marcelo: Comutations and KRASG12C inhibitor efficacy in advanced NSCLC / Marcelo V. Negrao, Haniel A. Araujo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou,… , March 29 2023. - 16 S. : Illustrationen
In: Cancer discovery, ISSN 2159-8290. 13(2023), 7, Seite 1556-1571
DOI: 10.1158/2159-8290.CD-22-1420
Christopoulos, Petros: Editorial: Systemic immune dysregulation in malignant disease : insights, monitoring and therapeutic exploitation / Petros Christopoulos and Udo S. Gaipl, 03 April 2023. - 5 S.
In: Frontiers in oncology, ISSN 2234-943X. 13(2023), Artikel-ID 1182081, Seite 1-5
DOI: 10.3389/fonc.2023.1182081
Goldschmid, Hannah: Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas / Hannah Goldschmid, Klaus Kluck, Markus Ball, Martina Kirchner, Michael Allgäuer, Hauke Winter, Felix… , June 2023. - 9 S. : Illustrationen
In: Lung cancer, ISSN 1872-8332. 180(2023) vom: Juni, Artikel-ID 107212, Seite 1-9
DOI: 10.1016/j.lungcan.2023.107212
Ou, Sai-Hong: Distribution and detectability of EGFR exon 20 insertion variants in NSCLC / Sai-Hong Ignatius Ou, MD, PhD, Jin-Liern Hong, PhD, Petros Christopoulos, MD, PhD, Huamao M. Lin, Ph… , June 2023. - 11 S. : Illustrationen
In: Journal of thoracic oncology, ISSN 1556-1380. 18(2023), 6 vom: Juni, Seite 744-754
DOI: 10.1016/j.jtho.2023.01.086
Krämer, Anna Sabrina: Upfront and repeated stereotactic radiosurgery in patients with brain metastases from NSCLC / Anna S. Krämer, Sebastian Adeberg, Dorothea Kronsteiner, Laila König, Fabian Schunn, Farastuk Bozorg… , 27 April 2023. - 9 S.
In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 3 vom: Apr., Seite 269-277
DOI: 10.1016/j.cllc.2023.01.002
Christopoulos, Petros: Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations / Petros Christopoulos, Thibaud Prawitz, Jin-Liern Hong, Huamao M. Lin, Luis Hernandez, Shu Jin, Min T… , 13 April 2023. - 7 S.
In: Lung cancer, ISSN 1872-8332. 179(2023) vom: Apr., Artikel-ID 107191, Seite 1-7
DOI: 10.1016/j.lungcan.2023.107191
Eichkorn, Tanja: High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes / Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antoni… , 13 January 2023. - 14 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2023) vom: Jan., Artikel-ID 1035370, Seite 1-14
DOI: 10.3389/fonc.2022.1035370
Gente, Karolina: Distinct immune-effector and metabolic profile of CD8+ T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors / Karolina Benesova, Franziska Viktoria Kraus, Rui A. Carvalho, Holger Lorenz, Christian H. Hörth, Jan… , 3 August 2022. - 12 S.
In: Annals of the rheumatic diseases, ISSN 1468-2060. 81(2022), 12, Seite 1730-1741
DOI: 10.1136/ard-2022-222451
Janke, Florian: Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients / Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Albrecht Stenz… , 02 December 2022. - 15 S. : Illustrationen
In: Clinical epigenetics, ISSN 1868-7083. 14(2022), Artikel-ID 163, Seite 1-15
DOI: 10.1186/s13148-022-01387-4
Baum, Philip: Trends in age- and sex-specific lung cancer mortality in Europe and Northern America : analysis of vital registration data from the WHO Mortality Database between 2000 and 2017 / Philip Baum, Hauke Winter, Martin E. Eichhorn, Romina M. Roesch, Samantha Taber, Petros Christopoulo… , 14 July 2022. - 11 S.
In: European journal of cancer, ISSN 1879-0852. 171(2022) vom: Aug., Seite 269-279
DOI: 10.1016/j.ejca.2022.05.011
Rheinheimer, Stephan: Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification : higher contrast uptake associated with response and better prognosis / Stephan Rheinheimer, Petros Christopoulos, Stella Erdmann, Julia Saupe, Heiko Golpon, Jens Vogel-Cla… , 05 December 2022. - 12 S. : Illustrationen
In: BMC medical imaging, ISSN 1471-2342. 22(2022), Artikel-ID 215, Seite 1-12
DOI: 10.1186/s12880-022-00943-x
Ruggieri, Matias: Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection / Matias Ruggieri, Nicolás Ducasa, Claudia Juraske, Virginia Gonzalez Polo, Carolina Berini, Maria Flo… , 11 August 2022. - 15 S.
In: Frontiers in immunology, ISSN 1664-3224. 13(2022), Artikel-ID 920888, Seite 1-15
DOI: 10.3389/fimmu.2022.920888
Schindler, Hannah: Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors / Hannah Schindler, Fabienne Lusky, Lea Daniello, Mariam Elshiaty, Lena Gaissmaier, Karolina Benesova,… , 31 October 2022. - 16 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2022) vom: Okt., Artikel-ID 1010660, Seite 1-16
DOI: 10.3389/fonc.2022.1010660
Kian, Waleed: Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer / Waleed Kian, Petros Christopoulos, Areen A. Remilah, Esther Levison, Elizabeth Dudnik, Walid Shalata… , 20 September 2022. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2022) vom: Sept., Artikel-ID 1010311, Seite 1-9
DOI: 10.3389/fonc.2022.1010311
Dimitrakopoulos, Foteinos-Ioannis: Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab : results from a European multicentre study / Foteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, Thomas Papastergiou, Mari… , September 8, 2022. - ? S.
In: Therapeutic advances in medical oncology, ISSN 1758-8359. 14(2022), Artikel-ID 17588359221122728, Seite 1-?
DOI: 10.1177/17588359221122728
Bozorgmehr, Farastuk: Protocol of the TREASURE study : Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease$da randomized, open-label, multicenter phase II trial / Farastuk Bozorgmehr, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisa… , 24 September 2022. - 9 S.
In: BMC cancer, ISSN 1471-2407. 22(2022), Artikel-ID 1011, Seite 1-9
DOI: 10.1186/s12885-022-10074-9
Rajakumar, Timothy: A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy / Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofma… , 31 March 2022. - 13 S.
In: npj precision oncology, ISSN 2397-768X. 6(2022), Artikel-ID 19, Seite 1-13
DOI: 10.1038/s41698-022-00262-y
Li, Yan: High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites : a case report / Yan Li, Peng Duan, Yan Guan, Qing Chen, Anna Grenda, Petros Christopoulos, Marc G. Denis, Qisen Guo, January 2022. - 11 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 11(2022), 1, Seite 100-110
DOI: 10.21037/tlcr-21-1039
Gu, Xiaodong: Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib : a case report / Xiaodong Gu, Wenxian Wang, Wei Wu, Yiping Zhang, Lan Shao, Mariacarmela Santarpia, Petros Christopou… , [May 2022]. - 8 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 11(2022), 5 vom: Mai, Seite 902-909
DOI: 10.21037/tlcr-22-288
Christopoulos, Petros: The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions / Petros Christopoulos, Klaus Kluck, Martina Kirchner, Heike Lüders, Julia Roeper, Roger-Fei Falkenste… , 20 May 2022. - 13 S.
In: European journal of cancer, ISSN 1879-0852. 170(2022) vom: Juli, Seite 106-118
DOI: 10.1016/j.ejca.2022.04.020
Sobol, Benjamin: Specific targeting of antiapoptotic Bcl-2 proteins as a radiosensitizing approach in solid tumors / Benjamin Sobol, Osama Azzam Nieto, Emily Lara Eberlein, Anna-Lena Scherr, Lars Ismail, Annika Kessle… , 16 July 2022. - 13 S.
In: International journal of molecular sciences, ISSN 1422-0067. 23(2022), 14, Artikel-ID 7850, Seite 1-13
DOI: 10.3390/ijms23147850
Blasi, Miriam: Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older : a propensity score-matched analysis / Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. H… , 28 June 2022. - 8 S.
In: BMC pulmonary medicine, ISSN 1471-2466. 22(2022), Artikel-ID 255, Seite 1-8
DOI: 10.1186/s12890-022-02043-6
Kunz, Julia: Early development of ubiquitous acanthocytosis and extravascular hemolysis in lung cancer patients receiving alectinib / Julia Kunz, Christiane Wiedemann, Heidrun Grosch, Katharina Kriegsmann, Stefanie Gryzik, Julia Felde… , 31 May 2022. - 13 S.
In: Cancers, ISSN 2072-6694. 14(2022), 11, Artikel-ID 2720, Seite 1-13
DOI: 10.3390/cancers14112720
Baum, Philip: Trends in age- and sex-specific lung cancer mortality in Europe and Northern America : analysis of vital registration data from the WHO Mortality Database between 2000 and 2017 / Philip Baum, Hauke Winter, Martin E. Eichhorn, Romina M. Roesch, Samantha Taber, Petros Christopoulo… , 20 June 2022. - 11 S.
In: European journal of cancer, ISSN 1879-0852. (2022) in press, corrected proof, Seite 1-11, 11 Seiten
DOI: 10.1016/j.ejca.2022.05.011
Roeper, Julia: Thorakale Onkologie : metastasierte Stadien / Julia Roeper, Nikolaj Frost, Martin Wermke, Felix C. Saalfeld, Daniel Heudobler, Tobias Pukrop, Mela… , 15. Februar 2022. - 6 S.
In: Der Onkologe, ISSN 1433-0415. 28(2022), Suppl.1, Seite S55-S60
DOI: 10.1007/s00761-022-01111-0
Roeper, Julia: TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy : EGFR mutated non-small cell lung cancer IV patients treated with osimertinib / Julia Roeper, Petros Christopoulos, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Albrecht Stenzing… , January 2022. - 13 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 11(2022), 1, Seite 4-16
DOI: 10.21037/tlcr-21-754
Budczies, Jan: Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma / Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Krie… , 14 June 2021. - 15 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 71(2022), 2, Seite 251-265
DOI: 10.1007/s00262-021-02981-w
Agaimy, Abbas: Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor of the lung / Abbas Agaimy, MD, Robert Stoehr, PhD, Michael Michal, MD, Petros Christopoulos, MD, Hauke Winter, MD… , November 2021. - 9 S.
In: The American journal of surgical pathology, ISSN 1532-0979. 45(2021), 11, Seite 1541-1549
DOI: 10.1097/PAS.0000000000001719
Kirchner, Martina: The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma / M. Kirchner, K. Kluck, R. Brandt, A.-L. Volckmar, R. Penzel, D. Kazdal, V. Endris, O. Neumann, H. Se… , 3 September 2021. - 12 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100253, Seite 1-12
DOI: 10.1016/j.esmoop.2021.100253
Mountzios, Giannis: Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer / G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. … , 1 September 2021. - 10 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100254, Seite 1-10
DOI: 10.1016/j.esmoop.2021.100254
Kazdal, Daniel: Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma / Daniel Kazdal, Eugen Rempel, Cristiano Oliveira, Michael Allgäuer, Alexander Harms, Kerstin Singer, … , April 2021. - 15 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 10(2021), Artikel-ID 4, Seite 1-15
DOI: 10.21037/tlcr-20-1168
Angeles, Arlou Kristina J.: Liquid biopsies beyond mutation calling : genomic and epenomic features of cell-free DNA in cancer / Arlou Kristina Angeles, Florian Janke, Simone Bauer, Petros Christopoulos, Anja Lisa Riediger and Ho… , 10 November 2021. - 20 S.
In: Cancers, ISSN 2072-6694. 13(2021), 22, Artikel-ID 5615, Seite 1-20
DOI: 10.3390/cancers13225615
Saalfeld, Felix: Efficacy of immune checkpoint inhibitors alone or in combination with chemotherapy in NSCLC harboring ERBB2 mutations / Felix C. Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach-Bruse, Timm M. Reissig, Si… , 8 July 2021. - 7 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 16(2021), 11, Seite 1952-1958
DOI: 10.1016/j.jtho.2021.06.025
Angeles, Arlou Kristina J.: Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis / Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, Simone Bauer, Florian Janke, Simon John Ogr… , 07 December 2021. - 12 S.
In: npj precision oncology, ISSN 2397-768X. 5(2021), Artikel-ID 100, Seite 1-12
DOI: 10.1038/s41698-021-00239-3
Christopoulos, Petros: Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping : study protocol of the ABP trial / Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, Inn Chung, Johannes Krisam, Marc A. Schnei… , 28 June 2021. - 10 S.
In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 743, Seite 1-10
DOI: 10.1186/s12885-021-08460-w
Christopoulos, Petros: Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies / Petros Christopoulos, Steffen Dietz, Arlou K. Angeles, Stephan Rheinheimer, Daniel Kazdal, Anna-Lena… , 2021. - 14 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 10(2021), 5 vom: Mai, Seite 2118-2131
DOI: 10.21037/tlcr-21-32
Hohmann, Nicolas: Pharmacoenhancement of low crizotinib plasma concentrations in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer using the CYP3A inhibitor cobicistat / Nicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos, Gerd Mikus, Antje Blank, Jürgen Burhenne… , 2021. - 5 S.
In: Clinical and translational science, ISSN 1752-8062. 14(2021), 2, Seite 487-491
DOI: 10.1111/cts.12921
El-Shafie, Rami: Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer / R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allg… , 2 June 2021. - 10 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 3, Artikel-ID 100161, Seite 1-10
DOI: 10.1016/j.esmoop.2021.100161
Daniello, Lea: Therapeutic and prognostic implications of immune-related adverse events in advanced non-small-cell lung cancer / Lea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, Jonas Kuon, Daniel Kazdal, Hannah Schindler, Raj… , 29 June 2021. - 14 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 29. Juni, Artikel-ID 703893, Seite 1-14
DOI: 10.3389/fonc.2021.703893
Fisch, David: Comprehensive dissection of treatment patterns and outcome for patients with metastatic large-cell neuroendocrine lung carcinoma / David Fisch, Farastuk Bozorgmehr, Daniel Kazdal, Jonas Kuon, Laura V. Klotz, Rajiv Shah, Florian Eic… , 08 July 2021. - 12 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 8. Juli, Artikel-ID 673901, Seite 1-12
DOI: 10.3389/fonc.2021.673901
Elshiaty, Mariam: Principles and current clinical landscape of multispecific antibodies against cancer / Mariam Elshiaty, Hannah Schindler and Petros Christopoulos, 26 May 2021. - 28 S.
In: International journal of molecular sciences, ISSN 1422-0067. 22(2021), 11, Artikel-ID 5632
DOI: 10.3390/ijms22115632
Griesinger, Frank: Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care : Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174-184] / Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz,… , 26 May 2021. - 1 S.
In: Lung cancer, ISSN 1872-8332. 157(2021) vom: Juli, Seite 167
DOI: 10.1016/j.lungcan.2021.05.005
Kriegsmann, Katharina: Role of synaptophysin, chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation : a retrospective large-scale study on 1170 tissue samples / Katharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos, Michael Thomas, Hau… , 01 May 2021. - 9 S.
In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 486, Seite 1-9
DOI: 10.1186/s12885-021-08140-9
Eichhorn, Florian: Prognostic impact of PD-L1 expression in pN1 NSCLC : a retrospective single-center analysis / Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zg… , 23 April 2021. - 13 S.
In: Cancers, ISSN 2072-6694. 13(2021), 9, Artikel-ID 2046, Seite 1-13
DOI: 10.3390/cancers13092046
Magios, Nikolaus: Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer / Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J. … , March 24, 2021. - 13 S.
In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835921996509, Seite 1-13
DOI: 10.1177/1758835921996509
Volckmar, Anna-Lena: Targeting rare and non-canonical driver variants in NSCLC : an uncharted clinical field / Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budc… , 19 February 2021. - 11 S.
In: Lung cancer, ISSN 1872-8332. 154(2021) vom: Apr., Seite 131-141
DOI: 10.1016/j.lungcan.2021.02.022
Bozorgmehr, Farastuk: De Novo versus secondary metastatic EGFR-mutated non-small-cell lung cancer / Farastuk Bozorgmehr, Daniel Kazdal, Inn Chung, Martina Kirchner, Nikolaus Magios, Mark Kriegsmann, M… , 09 April 2021. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021), Artikel-ID 640048, Seite 1-9
DOI: 10.3389/fonc.2021.640048
Baum, Philip: Validation of the T descriptor (TNM-8) in T3N0 non-small-cell lung cancer patients : a bicentric cohort analysis with arguments for redefinition / Philip Baum, Samantha Taber, Stella Erdmann, Thomas Muley, Mark Kriegsmann, Petros Christopoulos, Mi… , 10 April 2021. - 10 S.
In: Cancers, ISSN 2072-6694. 13(2021), 8, Artikel-ID 1812, Seite 1-10
DOI: 10.3390/cancers13081812
El Sayed, Mei: Feasibility and challenges for sequential treatments in ALK-rearranged non-small-cell lung cancer / Mei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, Anna-Lena Volckmar, Holger Sültmann, Jürgen R. Fisc… , 20 April 2021. - 8 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: Apr., Artikel-ID 670483, Seite 1-8
DOI: 10.3389/fonc.2021.670483
El Sayed, Mei: Therapeutic sequencing in ALK+ NSCLC / Mei Elsayed and Petros Christopoulos, 21 January 2021. - 17 S.
In: Pharmaceuticals, ISSN 1424-8247. 14(2021), 2, Artikel-ID 80, Seite 1-17
DOI: 10.3390/ph14020080
Frost, Nikolaj: Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations : results from the German early access program / Nikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, Jan Stratmann, Richard Riedel, Monica… , February 9, 2021. - 15 S.
In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835920980558, Seite 1-15
DOI: 10.1177/1758835920980558
Budczies, Jan: A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma / Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Krie… , 11 January 2021. - 14 S. : Illustrationen, Diagramme
In: OncoImmunology, ISSN 2162-402X. 10(2021), Artikel-ID 1860586, Seite 1-14
DOI: 10.1080/2162402x.2020.1860586
Dietz, Steffen: Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA / Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar,… , 9 November 2020. - 10 S.
In: EBioMedicine, ISSN 2352-3964. 62(2020), 12, Artikel-ID 103103, Seite 1-10
DOI: 10.1016/j.ebiom.2020.103103
Faehling, Martin: Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC) : real-world data on survival and safety from the German expanded-access program (EAP) / Martin Faehling, Christian Schumann, Petros Christopoulos, Petra Hoffknecht, Jürgen Alt, Marlitt Hor… , 21 October 2020. - 9 S. : Diagramme
In: Lung cancer, ISSN 1872-8332. 150(2020), 12, Seite 114-122
DOI: 10.1016/j.lungcan.2020.10.006
Kriegsmann, Katharina: Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer / Katharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos, Moritz von Winterfe… , 2020. - 15 S.
In: Histopathology, ISSN 1365-2559. 77(2020), 6, Seite 900-914
DOI: 10.1111/his.14203
Griesinger, Frank: Biomarker testing in non-small cell lung cancer in routine care : analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315) / Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz,… , 2021. - 11 S.
In: Lung cancer, ISSN 1872-8332. 152(2021) vom: Feb., Seite 174-184
DOI: 10.1016/j.lungcan.2020.10.012
Peled, Nir: GLASS : Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study$dreal world data of 123 NSCLC patients / Nir Peled, Roni Gillis, Saadettin Kilickap, Patrizia Froesch, Sergei Orlov, Elena Filippova, Umut De… , 27 July 2020. - 7 S.
In: Lung cancer: targets and therapy, ISSN 1179-2728. 148(2020), Seite 48-54
DOI: 10.1016/j.lungcan.2020.07.022
Christopoulos, Petros: Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing / P. Christopoulos, M. Kirchner, J. Roeper, F. Saalfeld, M. Janning, F. Bozorgmehr, N. Magios, D. Kazd… , 22 August 2020. - 8 S.
In: Lung cancer, ISSN 1872-8332. 148(2020), Seite 105-112
DOI: 10.1016/j.lungcan.2020.08.007
Wessels, Sabine: Comprehensive serial biobanking in advanced NSCLC : feasibility, challenges and perspectives / Sabine Wessels, Thomas Muley, Petros Christopoulos, Michael Meister, Ingrid Heinzmann-Groth, Arne Wa… , August 2020. - 15 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 9(2020), 4, Seite 1000-1014
DOI: 10.21037/tlcr-20-137
Eichkorn, Tanja: Consolidation immunotherapy after platinum-based chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer : cross-sectional study of eligibility and administration rates / Tanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, Lisa A. Dinges, Andreas Kudak, Nina Bougatf,… , 01 December 2020. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 10(2020) Artikel-Nummer 586449, 9 Seiten
DOI: 10.3389/fonc.2020.586449
Kriegsmann, Mark: Mass spectrometry imaging for reliable and fast classification of non-small cell lung cancer subtypes / Mark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, Kristina Schwamborn, Thomas Muley, Hauke Win… , 21 September 2020. - 14 S.
In: Cancers, ISSN 2072-6694. 12(2020,9) Artikel-Nummer 2704, 14 Seiten
DOI: 10.3390/cancers12092704
Bozorgmehr, Farastuk: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy : study protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 26 August 2020. - 10 S.
In: BMC cancer, ISSN 1471-2407. 20(2020) Artikel-Nummer 806, 9 Seiten
DOI: 10.1186/s12885-020-07264-8
Brückl, Wolfgang M.: Efficacy of docetaxel plus ramucirumab as palliative third-line therapy following second-line immune-checkpoint-inhibitor treatment in patients with non-small-cell lung cancer stage IV : $hWolfgang M. Brueckl, Martin Reck, Achim Rittmeyer, Jens Kollmeier, Claas Wesseler, Gunther H. Wiest, Petros Christopoulos, Amanda Tufman, Petra Hoffknecht, Bernhard Ulm, Fabian Reich, Joachim H. Ficker and Eckart Laack, August 19, 2020. - 9 S.
In: Clinical medicine insights, ISSN 1179-5549. 14(2020), Seite 1-9
DOI: 10.1177/1179554920951358
Rheinheimer, Stephan: Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors / Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke… , 23 April 2020. - 13 S.
In: Cancers, ISSN 2072-6694. 12(2020), 4, Artikel-ID 1046, Seite 1-13
DOI: 10.3390/cancers12041046
Budczies, Jan: Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement / Jan Budczies, Daniel Kazdal, Michael Allgäuer, Petros Christopoulos, Eugen Rempel, Nicole Pfarr, Wil… , 1 February 2020. - 6 S.
In: Lung cancer, ISSN 1872-8332. 142(2020), Seite 114-119
DOI: 10.1016/j.lungcan.2020.01.019
Eiff, Damian von: Paclitaxel for treatment of advanced small cell lung cancer (SCLC) : a retrospective study of 185 patients / Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, T… , [2020]. - 12 S.
In: Journal of thoracic disease, ISSN 2077-6624. 12(2020), 3, Seite 782-793
DOI: 10.21037/jtd.2019.12.74
Dietz, Steffen: Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer / Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J.… , November 21, 2019. - 10 S.
In: Cold Spring Harbor molecular case studies, ISSN 2373-2873. 5(2019,6) Artikel-Nummer a004630, 10 Seiten
DOI: 10.1101/mcs.a004630
Christopoulos, Petros: Defining molecular risk in ALK + NSCLC / Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas… , May 03, 2019. - 11 S.
In: OncoTarget, ISSN 1949-2553. 10(2019), 33, Seite 3093-3103
DOI: 10.18632/oncotarget.26886
Kazdal, Daniel: Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma : separating biology from technical artifacts / Daniel Kazdal, Volker Endris, Michael Allgäuer, Mark Kriegsmann, Jonas Leichsenring, Anna-Lena Volck… , 23 July 2019. - 13 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 14(2019), 11, Seite 1935-1947
DOI: 10.1016/j.jtho.2019.07.006
Budczies, Jan: Optimizing panel-based tumor mutational burden (TMB) measurement / J. Budczies, M. Allgäuer, K. Litchfield, E. Rempel, P. Christopoulos, D. Kazdal, V. Endris, M. Thoma… , 3 July 2019. - 11 S.
In: Annals of oncology, ISSN 1569-8041. 30(2019), 9, Seite 1496-1506
DOI: 10.1093/annonc/mdz205
Christopoulos, Petros: Charakterisierung der systemischen T-Zell-Dysregulation bei Großzelligen Neuroendokrinen Lungenkarzinomen, Thymomen und indolenten B-Zell Lymphomen / vorgelegt von Dr. med. Petros Christopoulos. -
Heidelberg, 2019. - 1 Band (verschiedene Seitenzählungen) : Illustrationen, Diagramme
Leichsenring, Jonas: Variant classification in precision oncology / Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Le… , 22 April 2019. - 15 S.
In: International journal of cancer, ISSN 1097-0215. 145(2019), 11, Seite 2996-3010
DOI: 10.1002/ijc.32358
Richtmann, Sarah: FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC / Sarah Richtmann, Dennis Wilkens, Arne Warth, Felix Lasitschka, Hauke Winter, Petros Christopoulos, F… , 11 May 2019. - 16 S.
In: Cancers, ISSN 2072-6694. 11(2019,5) Artikel-Nummer 652, 16 Seiten
DOI: 10.3390/cancers11050652
Christopoulos, Petros: Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival / Petros Christopoulos, Steffen Dietz, Martina Kirchner, Anna-Lena Volckmar, Volker Endris, Olaf Neuma… , 21 January 2019. - 9 S.
In: Cancers, ISSN 2072-6694. 11(2019,1) Artikel-Nummer 124, 9 Seiten
DOI: 10.3390/cancers11010124
Christopoulos, Petros: Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma / P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penz… , [1 January 2019]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 144(2019), 1, Seite 190-199
DOI: 10.1002/ijc.31893
Buchhalter, Ivo: Size matters : Dissecting key parameters for panel-based tumor mutational burden analysis / Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna-Lena Volckmar, Mar… , 2019. - 11 S.
In: International journal of cancer, ISSN 1097-0215. 144(2019), 4, Seite 848-858
DOI: 10.1002/ijc.31878
Volckmar, Anna-Lena: Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics : analysis of the first 3000 Heidelberg cases / Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Bu… , 17 January 2019. - 13 S.
In: International journal of cancer, ISSN 1097-0215. 145(2019), 3, Seite 649-661
DOI: 10.1002/ijc.32133
Allgäuer, Michael: Implementing tumor mutational burden (TMB) analysis in routine diagnostics : a primer for molecular pathologists and clinicians / Michael Allgäuer, Jan Budczies, Petros Christopoulos, Volker Endris, Amelie Lier, Eugen Rempel, Anna… , Aug 15, 2018. - 13 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 7(2018), 6, Seite 703-715
DOI: 10.21037/tlcr.2018.08.14
Budczies, Jan: Integrated analysis of the immunological and genetic status in and across cancer types : impact of mutational signatures beyond tumor mutational burden / Jan Budczies, Anja Seidel, Petros Christopoulos, Volker Endris, Matthias Kloor, Balázs Győrffy, Barb… , 19 Oct 2018. - 13 S.
In: OncoImmunology, ISSN 2162-402X. 7(2018), 12, Artikel-ID e1526613, Seite e1526613-1-e1526613-13
DOI: 10.1080/2162402X.2018.1526613
Toberer, Ferdinand: Double-positive CD8/CD4 primary cutaneous acral T-cell lymphoma / Ferdinand Toberer, Petros Christopoulos, Felix Lasitschka, Alexander Enk, Holger A. Haenssle, Lorenz… , 2019. - 3 S.
In: Journal of cutaneous pathology, ISSN 1600-0560. 46(2019), 3, Seite 231-233
DOI: 10.1111/cup.13403
Bernhardt, Denise: Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy / Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros … , 30 November 2018. - 7 S.
In: Cancer management and research, ISSN 1179-1322. 10(2018), Seite 6563-6569
DOI: 10.2147/CMAR.S180990
Christopoulos, Petros: Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance / Petros Christopoulos, Marc A. Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jen… , [May 2018]. - 8 S. : Illustrationen
In: Lung cancer, ISSN 1872-8332. 119(2018), Seite 48-55
DOI: 10.1016/j.lungcan.2018.03.002
Christopoulos, Petros: EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer / Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Rista… , [15 June 2018]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 142(2018), 12, Seite 2589-2598
DOI: 10.1002/ijc.31275
Christopoulos, Petros: Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features / Petros Christopoulos, Inn Chung, Farastuk Bozorgmehr, Thomas Muley, Michael Meister, Sonja Kobinger,… , [December 2018]. - 4 S. : Illustrationen
In: Histopathology, ISSN 1365-2559. 73(2018), 6, Seite 1040-1043
DOI: 10.1111/his.13724
Christopoulos, Petros: A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC / Petros Christopoulos, Michael Thomas, Feb 09, 2017. - 3 S.
In: Journal of thoracic disease, ISSN 2077-6624. 9(2017), 3, Seite E292-E294
DOI: 10.21037/jtd.2017.02.86
Christopoulos, Petros: Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma : a multicenter phase II trial / P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, … . - 5 S.
In: Annals of oncology, ISSN 1569-8041. 28(2017), 8, S. 1898-1902
DOI: 10.1093/annonc/mdx268
Schneider, Marc: AURKA, DLGAP5, TPX2, KIF11 and CKAP5 : five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients / Marc A. Schneider, Petros Christopoulos, Thomas Muley, Arne Warth, Ursula Klingmueller, Michael Thom… , 2017. - 8 S.
In: International journal of oncology, ISSN 1791-2423. 50(2017), 2, Seite 365-372
DOI: 10.3892/ijo.2017.3834
Christopoulos, Petros: Improved analysis of TCR[gamma][delta] variable region expression in humans / Petros Christopoulos, Daniela Bukatz, Sylvia Kock, Miroslav Malkovsky, Jürgen Finke, Paul Fisch. - 7 S.
In: Journal of immunological methods, ISSN 1872-7905. 434(2016), S. 66-72
DOI: 10.1016/j.jim.2016.04.009
Fisch, Paul: Response to comment on “A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression” / Paul Fisch, Petros Christopoulos, Alexander Marx and Wolfgang W. A. Schamel, 15 October 2015. - 2 S.
In: The journal of immunology, ISSN 1550-6606. 195(2015), 8, Seite 3505-3506
DOI: 10.4049/jimmunol.1501787

IDs

GND:

138659702

Links

Christopoulos, Petros in ...

Export publication list

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).

Impressum / Datenschutz Design